Borislava Ananieva
Capacity Building Officer & Patient Advocate, European Patients' Forum (EPF)
The congress' contributors
The congress'
Contributors
Steffen Thirstrup is a medical doctor and board-certified specialist in clinical pharmacology and therapeutics.Since June 2022 Prof Thirstrup has been the Chief Medical Officer at the European Medicines Agency, Amsterdam, The Netherlands.
From 2004 to 2009, he worked at Danish Medicines Agency first as the Danish member of CHMP at the European Medicines Agency (EMA) for five years including 10 months as joint CHMP- and CAT-member, and then as head of Danish Institute for Rational Pharmacotherapy dealing with HTA and best practice guidelines for primary care. In 2011, he rejoined the licensing division at the Danish Medicines Agency acting as Head of Division for Medicines Assessment and Clinical Trials. During this period Prof Thirstrup co-chaired the European Commission’s working group on market access for biosimilars medicinal products and acted as key scientific contact for the managing entity of the IMI beneficiaries for the PROTECT collaboration (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium). In 2013, he joined the pharmaceutical consultancy company NDA Group AB as a full-time medical advisor on NDA’s regulatory advisory board. In 2014, he was appointed as director for the Regulatory Advisory Board at NDA Regulatory Services Ltd.
He is author of more than 40 scientific papers, guidelines and text-book chapters as well as coeditor of 5th edition of Basal og Klinisk Farmakologi (Medical school pharmacology textbook in Danish). He holds a PhD in pharmacology and has a long background in clinical internal medicine with special emphasis on adult respiratory medicine. Additionally, he was appointed adjunct professor in pharmacotherapy at the Faculty of Health Sciences, University of Copenhagen, in 2012.
Capacity Building Officer & Patient Advocate, European Patients' Forum (EPF)
Strategic Partnerships, Senior Manager, European Patients' Forum (EPF)
Climate Projects Officer, Health Care Without Harm Europe (HCWH)
President, European Federation of Neurological Associations (EFNA)
President, Standing Committee of European Doctors (CPME)
Secretary General, European Alcohol Policy Alliance
Executive Director, Innovative Health Initiative Joint Undertaking
President & CEO, The Ehlers-Danlos Society
Director of Preference Research and Global Lead of the Patient-Centered Outcomes, OPEN Health
MD, Board Member, European Patients' Forum (EPF)
Senior Manager IVD, MedTech Europe
Executive Director, European Regional and Local Health Authorities (EUREGHA)
Director of Operations, Cyprus Federation of Patients’ Associations (CyFPA) and Board Treasurer, European Patients' Forum (EPF)
Board Member, European Patients' Forum (EPF) and Secretary General, Greek Patients' Organisation
Researcher & Populariser, Vaccination et Lien Social (VLS)
Senior Research Officer, Swedish Research Council
Chair, Council of Europe Steering Committee for Human Rights in the fields of Biomedicine and Health (CDBIO)
Director Government Affairs & Policy Medtech EMEA, Johnson & Johnson
WHO Representative to the EU
Executive Director, EUPATI
Deputy Director-General, Federal Ministry of Labour, Social Affairs, Health, Care and Consumer Protection, Austria
Deputy Administrator General, National Institute for Health and Disability Insurance (NIHDI)
President, European Patients' Forum (EPF)
Board Chair, Czech National Association of Patient Organizations (NAPO) & Board Member, European Patients' Forum (EPF)
Director for Executive Education in Government, Health and Non Profit Division, SDA Bocconi
Implementation Scientist & Qualitative Researcher, University of Antwerp
Policy Officer, DG SANTE, European Commission
Youth Group Member, European Patients' Forum (EPF)
President, European Liver Patient Association (ELPA)
Professor, Sorbonne Université
Regional Adviser Control of Antimicrobial Resistance, World Health Organisation/Europe (WHO/Europe)
Director HTA, National Agency for Regional Healthcare Services (AGENAS) and Co-Chair, HTA Member State Coordination Group (HTACG)
Youth Group Member, European Patients' Forum (EPF)
Director, Digital, EU4Health and Health systems modernisation, DG SANTE, European Commission
IMMUcan Scientific Lead, Gustave Roussy
VP International Access & Pricing, MSD International Business GmbH
CEO, Rigshospitalet
Director, European Federation of Allergy and Airways Diseases Patients' Associations (EFA)
Senior Economist, Organisation for Economic Co-operation and Development (OECD)
Head of Global Patient Engagement, Boehringer Ingelheim
European Affairs Advisor, France Assos Santé
Executive Director, Biomed Alliance
SVP International, Butterfly Network Inc
Director General, Association of the European Self-Care Industry (AESGP)
Vice President Corporate Affairs, Shionogi Europe
Public Affairs Director, OM Pharma
Chief Medical Officer, European Medicines Agency
Prof Dr, Erasmus University Rotterdam
Head of Unit, Policy and Coordination, HERA, European Commission
More speakers Announced soon
Stay Tuned!
CEO, Millwater Partners
Chief Partnership Officer, The Synergist
Regional Innovation Lead, NHS Greater Glasgow and Clyde Board (NHSGGC)
Policy Officer, European Patients' Forum (EPF)
PhD, MBA. Secretary of the Board at Health Technology Assessment international (HTAi).
Policy Officer, European Patients' Forum (EPF)
Head of Policy, European Patients' Forum (EPF)
Interim Executive Director, European Patients' Forum (EPF)
More moderators Announced soon
Stay Tuned!